ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0779
0.00%
Brent Oil
72.72
0.00%
Bitcoin
97,525.46
-0.24%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) Noticias

AMGN

Amgen (AMGN)

Amgen Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AMGN
FechaHoraFuenteTítuloSímboloCompañía
10/12/202415:30PR Newswire (US)AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDENDNASDAQ:AMGNAmgen Inc
07/12/202409:00PR Newswire (US)BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)NASDAQ:AMGNAmgen Inc
06/12/202417:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
05/12/202408:00PR Newswire (US)AMGEN ANNOUNCES $1 BILLION MANUFACTURING EXPANSION IN NORTH CAROLINANASDAQ:AMGNAmgen Inc
02/12/202415:00PR Newswire (US)AMGEN TO PRESENT AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
29/11/202415:30PR Newswire (US)AMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCENASDAQ:AMGNAmgen Inc
26/11/202406:05PR Newswire (US)AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDYNASDAQ:AMGNAmgen Inc
26/11/202406:00PR Newswire (US)AMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS AND PROGRESS ON DEVELOPMENT PROGRAMNASDAQ:AMGNAmgen Inc
20/11/202415:00PR Newswire (US)AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENTNASDAQ:AMGNAmgen Inc
14/11/202415:00PR Newswire (US)AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024NASDAQ:AMGNAmgen Inc
13/11/202414:27PR Newswire (US)MOORE LAW ENCOURAGES AMGEN INC. INVESTORS TO CONTACT LAW FIRMNASDAQ:AMGNAmgen Inc
13/11/202404:00PR Newswire (US)AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATANASDAQ:AMGNAmgen Inc
08/11/202415:00PR Newswire (US)AMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
08/11/202401:00PR Newswire (US)TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPSNASDAQ:AMGNAmgen Inc
31/10/202406:13IH Market NewsMicrosoft and Meta Decline Up to 4%; Roku Falls 14% Amid Lower Estimates; Booking Surges 6%; Carvana Soars 20%NASDAQ:AMGNAmgen Inc
30/10/202415:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMGNAmgen Inc
30/10/202415:01PR Newswire (US)AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
25/10/202415:00PR Newswire (US)AMGEN ANNOUNCES 2024 FOURTH QUARTER DIVIDENDNASDAQ:AMGNAmgen Inc
24/10/202415:00PR Newswire (US)AMGEN ANNOUNCES WEBCAST OF 2024 THIRD QUARTER FINANCIAL RESULTSNASDAQ:AMGNAmgen Inc
15/10/202407:00PR Newswire (US)AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024NASDAQ:AMGNAmgen Inc
01/10/202408:00PR Newswire (US)LA LA ANTHONY PARTNERS WITH AMGEN TO SHARE CANDID, BEHIND-THE-SCENES LOOK AT HOW PLAQUE PSORIASIS AFFECTS HER LIFENASDAQ:AMGNAmgen Inc
25/09/202415:45IH Market NewsDow, S&P Come Off Record Highs, Close On Weak NoteNASDAQ:AMGNAmgen Inc
24/09/202415:00PR Newswire (US)TEPEZZA® (TEPROTUMUMAB) RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ACTIVE THYROID EYE DISEASENASDAQ:AMGNAmgen Inc
23/09/202415:00PR Newswire (US)AMGEN TO HOST CONFERENCE CALL TO DISCUSS NEW TOPLINE DATA IN INFLAMMATION AND RARE DISEASENASDAQ:AMGNAmgen Inc
13/09/202408:00PR Newswire (US)AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024NASDAQ:AMGNAmgen Inc
09/09/202408:00PR Newswire (US)AMGEN PRESENTS NEW DATA FOR FIRST-IN-CLASS IMDELLTRA™ (TARLATAMAB-DLLE) IN SMALL CELL LUNG CANCER AT WCLC 2024NASDAQ:AMGNAmgen Inc
30/08/202415:00PR Newswire (US)AMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
29/08/202415:00PR Newswire (US)AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCENASDAQ:AMGNAmgen Inc
23/08/202415:20Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AMGNAmgen Inc
20/08/202408:00PR Newswire (US)OTEZLA® (APREMILAST) NOW AVAILABLE IN THE U.S. FOR MODERATE TO SEVERE PEDIATRIC PLAQUE PSORIASISNASDAQ:AMGNAmgen Inc
 Showing the most relevant articles for your search:NASDAQ:AMGN

Su Consulta Reciente

NYSE
NKE
Nike
COIN
BTCUSD
Bitcoin
NYSE
AXP
American Express
NYSE
BAC
Bank of America
NYSE
MRK
Merck
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AMZN
Amazon.com
USI
USTECH100
US Tech 100
NASDAQ
NVDA
NVIDIA
AMEX
XLV
Health Care Select Sector
USOTC
RHHBY
Roche (QX)
CCOM
US500
US 500
NYSE
MCD
McDonalds
NASDAQ
GOOGL
Alphabet
COIN
AVAXUSD
Avalanche
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados